We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Sees Improved Drug Safety, Risk Management as a Priority in PDUFA Talks
FDA Sees Improved Drug Safety, Risk Management as a Priority in PDUFA Talks
June 30, 2006
The FDA believes that improved use of epidemiological data and assessment of risk management plans (RMPs) are two priorities in its ongoing Prescription Drug User Fee Act (PDUFA) negotiations, a high-ranking agency official said.